Gossamer Bio
GOSS
GOSS
118 hedge funds and large institutions have $187M invested in Gossamer Bio in 2025 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 35 increasing their positions, 30 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
17% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 30
12% more funds holding
Funds holding: 105 → 118 (+13)
0.97% less ownership
Funds ownership: 75.62% → 74.65% (-0.97%)
Holders
118
Holding in Top 10
3
Calls
$2.93M
Puts
$117K
Top Buyers
| 1 | +$2.57M | |
| 2 | +$1.38M | |
| 3 | +$908K | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$884K |
| 5 |
AI
Atom Investors
Austin,
Texas
|
+$772K |
Top Sellers
| 1 | -$5.11M | |
| 2 | -$1.59M | |
| 3 | -$1.38M | |
| 4 |
EP
Eversept Partners
New York
|
-$1.19M |
| 5 |
Millennium Management
New York
|
-$999K |
